Invention Grant
- Patent Title: Angiopoietin-based interventions for treating cerebral malaria
-
Application No.: US16282199Application Date: 2019-02-21
-
Publication No.: US10525106B2Publication Date: 2020-01-07
- Inventor: Lisa Arleen Purcell , Sarah J. Higgins , Kevin C. Kain
- Applicant: Regeneron Pharmaceuticals, Inc. , University Health Network
- Applicant Address: US NY Tarrytown CA Toronto
- Assignee: Regeneron Pharmaceuticals, Inc.,University Health Network
- Current Assignee: Regeneron Pharmaceuticals, Inc.,University Health Network
- Current Assignee Address: US NY Tarrytown CA Toronto
- Agency: Schwabe, Williamson & Wyatt PC
- Agent Gabe Amodeo
- Main IPC: A61K31/365
- IPC: A61K31/365 ; A61K38/18 ; A61K38/16 ; A61K38/17 ; A61K39/395 ; C07K16/22 ; A61K45/06 ; A61K31/357 ; A61K31/49 ; C07K14/515 ; A61K39/00
Abstract:
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
Public/Granted literature
- US20190175699A1 Angiopoietin-Based Interventions for Treating Cerebral Malaria Public/Granted day:2019-06-13
Information query
